(Q7918002)

DrugBank

parenteral route of administration

17 November 2015

5.4 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=L04AA33

active ingredient in

Entyvio

1 reference

European Medicines Agency product number

EMEA/H/C/002782

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002782/human_med_001751.jsp

World Health Organisation international non-proprietary name

22 March 2017

vedolizumab (English)

1 reference

Vedolizumab (English)

medical condition treated

19 January 2016

graft-versus-host disease

1 reference

Drug Indications Extracted from FAERS

2 October 2018

ulcerative colitis

1 reference

Drug Indications Extracted from FAERS

2 October 2018

colitis

1 reference

Drug Indications Extracted from FAERS

imported from Wikimedia project

2 October 2018

pregnancy category

US pregnancy category B

1 reference

1 reference

Vedolizumab (English)

DrugBank

17 November 2015

gastrointestinal agent

1 reference

Medical Subject Headings

15 March 2018

1 reference

Vedolizumab (English)

publication date

17 November 2015

has part(s)

carbon

0 references

Identifiers

1 reference

Vedolizumab (English)

17 November 2015

1 reference

Vedolizumab (English)

19 January 2016

1 reference

World Health Organisation international non-proprietary name numeric ID

Vedolizumab (English)

publication date

17 November 2015

9093

0 references

Guide to Pharmacology Ligand ID

0 references

1 reference

Medical Subject Headings

14 March 2018

1 reference

26 February 2018

0 references

1 reference

VEDOLIZUMAB (English)

MedlinePlus drug identifier

19 January 2016

0 references

1 reference

VEDOLIZUMAB (English)

19 January 2016

1 reference

Vedolizumab (English)